MaxCyte Inc. is a leading life sciences and cell-based technology company that provides premier cell-engineering platforms to biopharmaceutical firms, academic institutions, and biotechnology developers. Its core offerings empower researchers and commercial manufacturers to optimize cellular modification for advanced cell therapies, gene editing, and immuno-oncology applications through proprietary, scalable electroporation solutions.